| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United Kingdom | 4 | |
| #2 | Australia | 3 | |
| #3 | Israel | 3 | |
| #4 | Republic of Korea | 3 | |
| #5 | EAPO (Eurasian Patent Organization) | 2 | |
| #6 | EPO (European Patent Office) | 1 | |
| #7 | Japan | 1 | |
| #8 | New Zealand | 1 | |
| #9 | Poland | 1 | |
| #10 | WIPO (World Intellectual Property Organization) | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Measurement |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Peptides | |
| #3 | Therapeutic chemical compounds | |
| #4 | Analysing materials |
| # | Name | Total Patents |
|---|---|---|
| #1 | Matossian-Rogers Arpi | 9 |
| #2 | Matossian Rogers Arpi | 3 |
| #3 | Arpi Matossian-Rogers | 1 |
| Publication | Filing date | Title |
|---|---|---|
| AU2012241141A1 | TCR-V-beta related peptides for treatment and diagnosis of autoimmune disease | |
| GB0609920D0 | Peptides | |
| GB0224896D0 | Peptides | |
| GB9810676D0 | Ligands including antibodies showing reactivity against endocrine cells for use in therapy and diagnosis | |
| GB9715281D0 | Ligands, including antibodies, showing reactivity against endocrine cells for use in therapy and diagnosis |